Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Chemoradiotherapy on Gastric Perfusion
NCT05354856Phase 4Terminated
- Sponsor
- Rigshospitalet
- Start
- Mar 2022
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of indocyanine green in gastric cancer (GC), sponsored by Rigshospitalet. Started Mar 2022; status: terminated.
02
Drugs
indocyanine green
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT05354856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05354856.